Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Hypertension. 2019 Dec 2;75(1):183–192. doi: 10.1161/HYPERTENSIONAHA.119.13866

Figure 4. Performance of a 17-steroid panel measured in peripheral serum for PA subtyping.

Figure 4.

A. Discriminant analysis between four PA subtypes at baseline and after cosyntropin stimulation. B. Receiver-operating characteristics curves for PA subtyping according to baseline and/or cosyntropin stimulated AVS results.

Grey line: baseline peripheral serum, to distinguish U vs. B PA subtyping based on baseline AVS results alone. Blue line: baseline peripheral serum for distinguishing PA subtypes based on both baseline and cosyntropin AVS data (U/U vs. B/B). Red line: cosyntropin-stimulated peripheral serum for distinguishing PA subtypes based on both baseline and cosyntropin AVS data (U/U vs. B/B).